由 Bentham Science出版。ISSN: 1871 - 5273。中樞神經(jīng)系統(tǒng)疾病-藥物靶標(biāo)旨在涵蓋所有最新和杰出的發(fā)展，在藥物化學(xué)，藥理學(xué)，分子生物學(xué)，基因組學(xué)和生物化學(xué)的當(dāng)代分子靶標(biāo)涉及神經(jīng)和中樞神經(jīng)系統(tǒng)疾病，如疾病特異性蛋白，受體，酶，基因。每一期的雜志將包含一系列由該領(lǐng)域的領(lǐng)導(dǎo)者撰寫的及時深入的評論，涵蓋當(dāng)前涉及神經(jīng)和中樞神經(jīng)系統(tǒng)疾病的藥物靶點的一系列主題。隨著用于神經(jīng)和中樞神經(jīng)系統(tǒng)藥物發(fā)現(xiàn)的新型人類藥物靶點的發(fā)現(xiàn)、鑒定、表征和驗證的不斷增長;這本雜志將是所有參與藥物發(fā)現(xiàn)和開發(fā)的藥物學(xué)家的必讀書。以前的藥物目標(biāo)-中樞神經(jīng)系統(tǒng)和神經(jīng)系統(tǒng)疾病(1568-007X)。

Published by Bentham Science Publishers. ISSN: 1871-5273.CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development. Formerly Current Drug Targets - CNS & Neurological Disorders (1568-007X).